NCT05076409View on ClinicalTrials.gov

A Study in Healthy Men to Test How Fluconazole Influences the Amount of BI 425809 in the Blood

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

October 19, 2021

Primary Completion Date

January 10, 2022

Study Completion Date

January 10, 2022

Conditions
Healthy
Interventions
DRUG

BI 425809

Period 1 and period 2

DRUG

fluconazole

Period 2

Trial Locations (1)

88397

Humanpharmakologisches Zentrum Biberach, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT05076409 - A Study in Healthy Men to Test How Fluconazole Influences the Amount of BI 425809 in the Blood | Biotech Hunter | Biotech Hunter